SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dynavax DVAX
An SI Board Since August 2004
Posts SubjectMarks Bans Symbol
184 23 0 DVAX
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
159FWIW, Feuerstein says a total of 5 dropped out. He adds those back, redoes the tuck-5/17/2018
158One intent is to include weakly antigenic cancers under the pembro umbrella, andscaram(o)uche-5/17/2018
157Watch Dynavax (DVAX) @ current levels on ACIP's recommendations for its Hepastocker22-4/23/2018
156Actually feels like there may be a dime or two in the share price for SD-101, whscaram(o)uche-4/12/2018
155Just for the heck of it I looked at implied volatility of DVAX options. Yawn. tuck-2/21/2018
154You are watching the ACIP meeting outcome? Starts tomorrow; important . . tuck12/20/2018
153New corporate presentation, no flavoring for TLR7/TR8 agonist..... files.sharehscaram(o)uche-2/5/2018
152Vaccine. 2018 Jan 29;36(5):668-674. doi: 10.1016/j.vaccine.2017.12.038. Epub 201scaram(o)uche12/5/2018
151>> So one less shot on goal << But add one back..... clinicaltrialscaram(o)uche-2/4/2018
150AZD1419 makes the cut??...... endpts.com edit: yes, made cut..... astrazenecscaram(o)uche-2/2/2018
149preclinical (mice)..... twitter.comscaram(o)uche-2/1/2018
148Wo. Thank you, I didn't even know about this trial. CT.gov lists the termiscaram(o)uche-1/23/2018
147Meanwhile, Merck gives up already on the SD-101/anti-IL-10 combo: Dose Evaluatituck-1/23/2018
146Sorry, listened to JPM presentation again.... they expect 35-40 more patientsscaram(o)uche-1/22/2018
145Not clear if the phase II results will make ASCO. Update expected mid-year, so scaram(o)uche-1/22/2018
144DVAX launches. Bewildered that the PRODUCT could be brought out of mothball to scaram(o)uche-1/8/2018
1438-K out, contract with this outfit for vaccine detailing...... inventivhealth.cscaram(o)uche-11/14/2017
142ATM was increased by $25m a few days ago. My basis went from about $4 to $17.40scaram(o)uche-11/14/2017
141AZD1419 trial recently updated....... dynavax.com And I don't know if anyoscaram(o)uche-11/14/2017
140pbs.twimg.comscaram(o)uche111/9/2017
139Dino, if you're out there........ congratulations! Adjuvants...... scaram(o)uche-11/9/2017
138We have reinitiated preparations for the launch of HEPLISAV-B, including resumptscaram(o)uche-11/3/2017
137On watch for clear above 19.60. [graphic]hollyhunter-9/6/2017
136"Dynavax anticipates using the net proceeds from the proposed offering to fscaram(o)uche-8/9/2017
135Oh wow. Priced at 15. Wow, wow, wow. Gray should get tarred (cold, harmless) scaram(o)uche-8/9/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News